Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT06046235
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of severe or moderate haemophilia (FVIII or FIX ≤ 5%)
* Aged \> 12 years of age
* Inhibitor or non-inhibitor, previous or current
Exclusion Criteria:
* Diagnosis of mild haemophilia (FVIII or FIX \> 5%)
* Diagnosis of von Willebrand Disease or other bleeding disorder
* Aged ≤ 12 years of age
* Participants requiring a sterile environment
* The use of an oxygen-rich environment at a participant's home
* Participants or another person at the participant's home, with sensitive medical equipment whose functions may be compromised by the introduction of the IMU units, such as a pacemaker or implantable defibrillator
* Bedridden patients
* Patients with severe cognitive or psychiatric disorders as confirmed by a medical diagnosis
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT06046235
Study Brief:
Protocol Section:
NCT06046235